ENTA icon

Enanta Pharmaceuticals
ENTA

Overview Fund Activity

154 hedge funds and large institutions have $856M invested in Enanta Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 55 increasing their positions, 59 reducing their positions, and 21 closing their positions.

Holders
154
Holders Change
-15
Holders Change %
-8.88%
% of All Funds
2.6%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
10
Increased
55
Reduced
59
Closed
21
Calls
$7.16M
Puts
$619K
Net Calls
+$6.54M
Net Calls Change
+$3.81M

Top Buyers

1
State Street
1
State Street
Massachusetts
$80.3M
2
Invesco
2
Invesco
Georgia
$23.6M
3
PBA
3
Paradigm Biocapital Advisors
New York
$7.01M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$8.4M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$16.6M

Top Sellers

1
First Manhattan
1
First Manhattan
New York
$10.8M
2
DTC
2
Deep Track Capital
Connecticut
$0
3
SCM
3
Stonepine Capital Management
Oregon
$0
4
SCM
4
Soleus Capital Management
Connecticut
$4.73M
5
Walleye Capital
5
Walleye Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$166M 3,518,736 +2,130 +0.1%
State Street
2
State Street
Massachusetts
$80.3M 1,699,428 +390,842 +30%
FCM
3
Farallon Capital Management
California
$73.3M 1,550,000 – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$71.7M 1,516,689 -72,535 -5%
Northern Trust
5
Northern Trust
Illinois
$44M 931,291 +3,198 +0.3%
RCM
6
RA Capital Management
Massachusetts
$42.4M 896,724 -67,488 -7%
KAM
7
Krensavage Asset Management
New York
$29.5M 624,768 +75,940 +14%
Renaissance Technologies
8
Renaissance Technologies
New York
$25.7M 542,800 -64,300 -11%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$24.8M 523,709 -69,811 -12%
Invesco
10
Invesco
Georgia
$23.6M 499,530 +157,523 +46%
FFM
11
Fairmount Funds Management
Pennsylvania
$22.2M 469,264 – –
Fidelity Investments
12
Fidelity Investments
Massachusetts
$16.6M 350,333 +108,161 +45%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$16.4M 346,272 -6,444 -2%
Jacobs Levy Equity Management
14
Jacobs Levy Equity Management
New Jersey
$14.1M 297,532 +19,109 +7%
Morgan Stanley
15
Morgan Stanley
New York
$11.6M 244,874 +78,326 +47%
First Manhattan
16
First Manhattan
New York
$10.8M 227,807 -561,504 -71%
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$8.9M 188,343 -4,716 -2%
JPMorgan Chase & Co
18
JPMorgan Chase & Co
New York
$8.4M 177,654 +138,097 +349%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$7.93M 167,795 -14,906 -8%
PBA
20
Paradigm Biocapital Advisors
New York
$7.01M 148,216 +148,216 New
Norges Bank
21
Norges Bank
Norway
$6.59M 139,506 – –
Goldman Sachs
22
Goldman Sachs
New York
$6.54M 138,356 +37,855 +38%
TCM
23
Tang Capital Management
California
$6.51M 137,700 +37,700 +38%
Assenagon Asset Management
24
Assenagon Asset Management
Luxembourg
$6.49M 137,266 +2,080 +2%
Charles Schwab
25
Charles Schwab
California
$6.35M 134,231 -1,895 -1%
1
2 3 4 5